-+ 0.00%
-+ 0.00%
-+ 0.00%

PARABILIS MEDICINES PRESENTS UPDATED PHASE 1/2 DATA FOR ZOLUCATETIDE DEMONSTRATING COMPELLING EFFICACY AND FAVORABLE SAFETY AND TOLERABILITY PROFILE IN PATIENTS WITH DESMOID TUMORS

Reuters·10/24/2026 12:45:48

Please log in to view news